Health experts are on the verge of possibly having two COVID-19 vaccines and ABC13 has learned how the two compare. SEE RELATED STORY: US COVID-19 vaccinations ramp up as Moderna shot nears ...
SAN FRANCISCO -- Another COVID-19 vaccine -- AstraZeneca -- is poised to arrive in the U.S., bringing a fourth option for Americans. Each vaccine is administered slightly differently, some can result ...
Moderna is suing Pfizer and BioNTech for infringing patents central to Moderna's mRNA technology platform used to develop the COVID vaccine, the company said in a press release Friday. A widely ...
LONDON, July 10 (Reuters) - Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents, in ...
Last year, the High Court ruled that one of Moderna’s patents relating to the messenger RNA (mRNA) technology, which underpinned its COVID-19 vaccine, was valid and that Pfizer and BioNTech’s ...
Pfizer Inc.'s (NYSE:PFE) COVID-19 vaccine for children under five may lose U.S. Food and Drug Administration authorization this fall, raising the possibility of supply shortages and prompting Moderna ...
Hosted on MSN
Covid vaccine connection to children's deaths! Pfizer, Moderna and Novavax shares tumbled
Vaccine Stocks Plunge as U.S. Officials Probe Alleged Link Between Covid Shots and Child Deaths Shares of leading Covid-19 vaccine makers Pfizer, Moderna, and Novavax tumbled sharply on Friday after ...
Millions of dollars in cuts to vaccine technology. Canceled research. Mass resignations at the Centers for Disease Control and Prevention. Overhauled health councils and ever-changing guidelines that ...
In the second and final day of the Centers for Disease Control and Prevention's (CDC’s) Advisory Committee on Immunization Practices (ACIP) September meeting, members of the panel scrapped one vote, ...
LONDON, Aug 1 (Reuters) - Pfizer (PFE.N), opens new tab and its German partner BioNTech (22UAy.DE), opens new tab on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...
LONDON (Reuters) -Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents at London's Court of Appeal. Last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback